title: Argatroban therapy in patients with hepatic and renal impairment.
authors.forename: P-A
authors.initials: PA
authors.lastname: Brand
authors.forename: J-H
authors.initials: JH
authors.lastname: Egberts
authors.forename: J
authors.initials: J
authors.lastname: Scholz
authors.forename: N
authors.initials: N
authors.lastname: Weiler
authors.forename: B
authors.initials: B
authors.lastname: Bein
mesh_terms: D058186:Acute Kidney Injury / Q000150:complications; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D003422:Critical Care; D016638:Critical Illness; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000150:complications; D008297:Male; D010875:Pipecolic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D013449:Sulfonamides
chemical_list: D000925:Anticoagulants; D010875:Pipecolic Acids; D013449:Sulfonamides; D001120:Arginine; C031942:argatroban